Rockwell Medical, INC 8-K filings

NASDAQ
Rockwell Medical and Evoqua Water Technologies have amended their asset purchase agreement, resulting in an extended payment schedule and a partial reduction of deferred payments for Rockwell.
NASDAQ
Rockwell Medical's 2024 Annual Meeting saw the election of two Class III directors, approval of executive compensation, and ratification of the company's auditor.
NASDAQ
Rockwell Medical, Inc. has released an updated corporate presentation on May 14, 2024, providing insights into the company's current status and future outlook.
NASDAQ
Rockwell Medical announced record net sales for the first quarter of 2024 and raised its full-year 2024 guidance for net sales, gross profit, and adjusted EBITDA.
NASDAQ
Rockwell Medical, Inc. has released an updated corporate presentation on March 21, 2024, providing insights into the company's current status and future outlook.
NASDAQ
Rockwell Medical reports record net sales and achieves profitability on an adjusted EBITDA basis for the first time in the company's history in the fourth quarter of 2023.